Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Pyroglutamic acidosis as a cause for high anion gap metabolic acidosis: a prospective study.

Spector SR, Mayan H, Loebstein R, Markovits N, Priel E, Massalha E, Shafir Y, Gueta I.

Sci Rep. 2019 Mar 5;9(1):3554. doi: 10.1038/s41598-019-39257-4.

2.

DNA Topoisomerase IB as a Potential Ionizing Radiation Exposure and Dose Biomarker.

Daudee R, Gonen R, German U, Orion I, Alfassi ZB, Priel E.

Radiat Res. 2018 Jun;189(6):652-660. doi: 10.1667/RR14859.1. Epub 2018 Apr 10.

PMID:
29633912
3.

Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT.

Davidson T, Priel E, Schiby G, Raskin S, Chikman B, Nissan E, Benjamini O, Nissan J, Goshen E, Ben-Haim S, Salomon O, Avigdor A.

Abdom Radiol (NY). 2018 Sep;43(9):2369-2374. doi: 10.1007/s00261-017-1454-3.

PMID:
29460043
4.

Hypermagnesuria in Humans Following Acute Intravenous Administration of Digoxin.

Abu-Amer N, Priel E, Karlish SJD, Farfel Z, Mayan H.

Nephron. 2018;138(2):113-118. doi: 10.1159/000481468. Epub 2017 Oct 30.

PMID:
29169235
5.

Multimodal Imaging in an Unusual Cluster of Multiple Evanescent White Dot Syndrome.

Gal-Or O, Priel E, Rosenblatt I, Shulman S, Kramer M.

J Ophthalmol. 2017;2017:7535320. doi: 10.1155/2017/7535320. Epub 2017 May 11.

6.

Differential decrease in soluble and DNA-bound telomerase in senescent human fibroblasts.

Yehuda S, Yanai H, Priel E, Fraifeld VE.

Biogerontology. 2017 Aug;18(4):525-533. doi: 10.1007/s10522-017-9688-6. Epub 2017 Mar 1.

PMID:
28251405
7.

Expression of functional alternative telomerase RNA component gene in mouse brain and in motor neurons cells protects from oxidative stress.

Eitan E, Tamar A, Yossi G, Peleg R, Braiman A, Priel E.

Oncotarget. 2016 Nov 29;7(48):78297-78309. doi: 10.18632/oncotarget.13049.

8.

25-Gauge Vitrectomy with Epiretinal Membrane and Internal Limiting Membrane Peeling in Eyes with Very Good Visual Acuity.

Moisseiev E, Kinori M, Moroz I, Priel E, Moisseiev J.

Curr Eye Res. 2016 Oct;41(10):1387-1392. Epub 2016 Feb 10.

PMID:
26862944
9.

Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human Microcirculation.

Beyer AM, Freed JK, Durand MJ, Riedel M, Ait-Aissa K, Green P, Hockenberry JC, Morgan RG, Donato AJ, Peleg R, Gasparri M, Rokkas CK, Santos JH, Priel E, Gutterman DD.

Circ Res. 2016 Mar 4;118(5):856-66. doi: 10.1161/CIRCRESAHA.115.307918. Epub 2015 Dec 23.

10.

Excitotoxic and Radiation Stress Increase TERT Levels in the Mitochondria and Cytosol of Cerebellar Purkinje Neurons.

Eitan E, Braverman C, Tichon A, Gitler D, Hutchison ER, Mattson MP, Priel E.

Cerebellum. 2016 Aug;15(4):509-17. doi: 10.1007/s12311-015-0720-6.

11.

Spectral-domain optical coherence tomographic features of choroidal neovascular membranes in multifocal choroiditis and punctate inner choroidopathy.

Amer R, Priel E, Kramer M.

Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):949-57. doi: 10.1007/s00417-015-2930-5. Epub 2015 Jan 29.

PMID:
25631844
12.

Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.

Peleg R, Romzova M, Kogan-Zviagin I, Apte RN, Priel E.

BMC Cancer. 2014 Dec 3;14:910. doi: 10.1186/1471-2407-14-910.

13.

Human cytomegalovirus viral load in tumor and peripheral blood samples of patients with malignant gliomas.

Priel E, Wohl A, Teperberg M, Nass D, Cohen ZR.

J Clin Neurosci. 2015 Feb;22(2):326-30. doi: 10.1016/j.jocn.2014.06.099. Epub 2014 Oct 28.

PMID:
25443081
14.
15.

Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.

Laster BH, Isaacson C, Perets E, Msamra M, Priel E, Kalef-Ezra J, Kost J.

J Cancer Res Clin Oncol. 2015 Jan;141(1):23-34. doi: 10.1007/s00432-014-1747-7. Epub 2014 Jul 30.

PMID:
25073436
16.

Topoisomerase I as a target of erlotinib and gefitinib: efficacy of combined treatments with camptothecin.

Peleg R, Bobilev D, Priel E.

Int J Oncol. 2014 Mar;44(3):934-42. doi: 10.3892/ijo.2014.2244. Epub 2014 Jan 7.

PMID:
24399039
17.

Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.

Schaap-Fogler M, Amer R, Friling R, Priel E, Kramer M.

Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):633-40. doi: 10.1007/s00417-013-2552-8. Epub 2013 Dec 24.

PMID:
24366669
18.

Fundus autofluorescence imaging in multifocal choroiditis: beyond the spots.

Kramer M, Priel E.

Ocul Immunol Inflamm. 2014 Oct;22(5):349-55. doi: 10.3109/09273948.2013.855797. Epub 2013 Dec 11.

PMID:
24329681
19.

Inhibition of topoisomerase I by anti-cancer drug altered the endometrial cyclicity and receptivity.

Liani-Leibson K, Har-Vardi I, Priel E.

Curr Mol Med. 2014 Jan;14(1):141-50.

PMID:
24236456
20.

Mycoplasma fermentans inhibits the activity of cellular DNA topoisomerase I by activation of PARP1 and alters the efficacy of its anti-cancer inhibitor.

Afriat R, Horowitz S, Priel E.

PLoS One. 2013 Aug 27;8(8):e72377. doi: 10.1371/journal.pone.0072377. eCollection 2013.

21.

Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individuals.

Tichon A, Eitan E, Kurkalli BG, Braiman A, Gazit A, Slavin S, Beith-Yannai E, Priel E.

Curr Mol Med. 2013 Jul;13(6):1010-22.

PMID:
23590815
22.

Telomerase expression in adult and old mouse Purkinje neurons.

Eitan E, Tichon A, Daniel G, Priel E.

Rejuvenation Res. 2012 Apr;15(2):206-9. doi: 10.1089/rej.2011.1285.

PMID:
22533433
23.

Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis.

Eitan E, Tichon A, Gazit A, Gitler D, Slavin S, Priel E.

EMBO Mol Med. 2012 Apr;4(4):313-29. doi: 10.1002/emmm.201200212. Epub 2012 Feb 20.

24.

Type 1 diabetes affects topoisomerase I activity and GlcNAcylation in rat organs: kidney, liver and pancreas.

Levi I, Segev Y, Priel E.

Glycobiology. 2012 May;22(5):704-13. doi: 10.1093/glycob/cws008. Epub 2012 Jan 12.

PMID:
22247452
25.

Digital versus film stereo-photography for assessment of the optic nerve head in glaucoma and glaucoma suspect patients.

Hasanreisoglu M, Priel E, Naveh L, Lusky M, Weinberger D, Benjamini Y, Gaton DD.

J Glaucoma. 2013 Mar;22(3):238-42. doi: 10.1097/IJG.0b013e31823298da.

PMID:
21946551
26.

Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.

Reuveni D, Halperin D, Shalit I, Priel E, Fabian I.

Int J Oncol. 2010 Aug;37(2):463-71.

PMID:
20596674
27.

Bevacizumab for choroidal neovascularization related to inflammatory diseases.

Kramer M, Axer-Siegel R, Jaouni T, Reich E, Hemo I, Priel E, Averbukh E, Ehrlich R, Chowers I, Weinberger D, Amer R.

Retina. 2010 Jun;30(6):938-44. doi: 10.1097/IAE.0b013e3181c96a00.

PMID:
20168273
28.

Photodynamic therapy for choroidal neovascularization in young adult patients.

Ehrlich R, Kramer M, Rosenblatt I, Weinberger D, Mimouni K, Priel E, Axer-Siegel R.

Int Ophthalmol. 2010 Aug;30(4):345-51. doi: 10.1007/s10792-010-9346-3. Epub 2010 Feb 2.

PMID:
20127140
29.

Acquired resistance to 6-thioguanine in melanoma cells involves the repair enzyme O6-methylguanine-DNA methyltransferase (MGMT).

Gefen N, Brkic G, Galron D, Priel E, Ozer J, Benharroch D, Gopas J.

Cancer Biol Ther. 2010 Jan;9(1):49-55. Epub 2010 Jan 9.

PMID:
19946217
30.

Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals.

Tichon A, Gowda BK, Slavin S, Gazit A, Priel E.

Cytotherapy. 2009;11(7):837-48. doi: 10.3109/14653240903136979.

PMID:
19903097
31.

Glutamate regulates the activity of topoisomerase I in mouse cerebellum.

Zehorai E, Eitan E, Hershfinkel M, Sekler I, Priel E.

Mol Neurobiol. 2008 Dec;38(3):242-52. doi: 10.1007/s12035-008-8044-x. Epub 2008 Nov 4.

PMID:
18982460
32.

Outcome of bevacizumab (Avastin) injection in patients with age-related macular degeneration and low visual acuity.

Ehrlich R, Weinberger D, Priel E, Axer-Siegel R.

Retina. 2008 Oct;28(9):1302-7. doi: 10.1097/IAE.0b013e3181803c2a.

PMID:
18664935
33.

Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.

Reuveni D, Halperin D, Shalit I, Priel E, Fabian I.

Biochem Pharmacol. 2008 Mar 15;75(6):1272-81. doi: 10.1016/j.bcp.2007.11.014. Epub 2007 Dec 3.

PMID:
18191106
34.

Modification of topoisomerase I activity by glucose and by O-GlcNAcylation of the enzyme protein.

Noach N, Segev Y, Levi I, Segal S, Priel E.

Glycobiology. 2007 Dec;17(12):1357-64. Epub 2007 Oct 11.

PMID:
17932134
35.
36.

DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties.

Har-Vardi I, Mali R, Breietman M, Sonin Y, Albotiano S, Levitas E, Potashnik G, Priel E.

Hum Reprod. 2007 Aug;22(8):2183-9.

PMID:
17656417
37.

HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor.

Kogan NM, Schlesinger M, Priel E, Rabinowitz R, Berenshtein E, Chevion M, Mechoulam R.

Mol Cancer Ther. 2007 Jan;6(1):173-83.

38.

A fatal effect of hornet venom on rat-brain cortical neurons.

Cohen-Armon M, Visochek L, Priel E, Ishay JS.

Chem Biodivers. 2006 May;3(5):535-43.

PMID:
17193289
39.

Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.

Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D.

Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec;37(6):455-61.

PMID:
17152538
40.

Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.

Fabian I, Reuveni D, Levitov A, Halperin D, Priel E, Shalit I.

Br J Cancer. 2006 Oct 23;95(8):1038-46.

41.

DNA topoisomerase I in the mouse central nervous system: Age and sex dependence.

Plaschkes I, Silverman FW, Priel E.

J Comp Neurol. 2005 Dec 19;493(3):357-69.

PMID:
16261531
42.

PolyADP-ribosylation is involved in neurotrophic activity.

Visochek L, Steingart RA, Vulih-Shultzman I, Klein R, Priel E, Gozes I, Cohen-Armon M.

J Neurosci. 2005 Aug 10;25(32):7420-8.

43.

Implications of the evolution pattern of human T-cell leukemia retroviruses on their pathogenic virulence (Review).

Azran I, Schavinsky-Khrapunsky Y, Priel E, Huleihel M, Aboud M.

Int J Mol Med. 2004 Nov;14(5):909-15. Review.

PMID:
15492865
44.

Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.

Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M.

Am J Ophthalmol. 2004 Oct;138(4):602-7.

PMID:
15488787
45.

DNA topoisomerase I as one of the cellular targets of certain tyrphostin derivatives.

Bendetz-Nezer S, Gazit A, Priel E.

Mol Pharmacol. 2004 Sep;66(3):627-34.

PMID:
15322255
46.

Indocyanine green angiography in high myopia.

Axer-Siegel R, Cotlear D, Priel E, Rosenblatt I, Snir M, Weinberger D.

Ophthalmic Surg Lasers Imaging. 2004 Mar-Apr;35(2):139-45.

PMID:
15088824
47.

Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.

Axer-Siegel R, Ehrlich R, Rosenblatt I, Kramer M, Priel E, Yassur Y, Weinberger D.

Arch Ophthalmol. 2004 Apr;122(4):453-9.

PMID:
15078661
48.

Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns.

Axer-Siegel R, Ehrlich R, Yassur Y, Rosenblatt I, Kramer M, Priel E, Benjamini Y, Weinberger D.

Am J Ophthalmol. 2004 Feb;137(2):258-64.

PMID:
14962414
49.

Revealing the mode of action of DNA topoisomerase I and its inhibitors by atomic force microscopy.

Argaman M, Bendetz-Nezer S, Matlis S, Segal S, Priel E.

Biochem Biophys Res Commun. 2003 Feb 14;301(3):789-97.

PMID:
12565850
50.

Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization.

Axer-Siegel R, Bourla D, Priel E, Yassur Y, Weinberger D.

Ophthalmology. 2002 Sep;109(9):1726-36.

PMID:
12208724

Supplemental Content

Support Center